Verastem | VSTM - Ingresos Por Ventas





Ventas Cambio Fecha
AbbVie USD 16.99B 1.99B 2026-06
Alaunos Therapeutics USD 2K 2K 2025-03
AstraZeneca USD 15.38B 90M 2026-06
Curis USD 1.14M 1.41M 2025-12
Cytokinetics USD 28.6M 9.25M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
Incyte USD 1.67B 400M 2026-06
Laboratory Of America USD 3.73B 190M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
TG Therapeutics USD 240.34M 45.54M 2026-06
Verastem USD 18.67M 1.14M 2026-03